Episode Details

Vecuronium is an intermediate-acting, nondepolarizing neuromuscular blocking agent used for skeletal muscle relaxation during surgery, mechanical ventilation, and endotracheal intubation, including rapid-sequence intubation (RSI).

1. Critical Safety & Boxed Warning (The Vital 20%)

• Respiratory Paralysis: Causes respiratory paralysis (potentially fatal). Administer only by experienced clinicians in settings with immediate intubation, ventilation, oxygen, and reversal agents.
• Induction Prerequisite: To prevent extreme distress, vecuronium must only be administered after unconsciousness is induced with adequate amnesia, sedation, and analgesia.
• Storage Warning: Due to risk of fatal accidental administration, store vials with cap/ferrule intact and separated from other drugs to prevent selection errors.

2. Mechanism of Action & Pharmacokinetics

• Mechanism: Competes with acetylcholine (ACh) for receptors at the motor end-plate. Paralysis progresses predictably: fine muscles (eyes, face, neck) first, then limbs, chest, abdomen, and lastly the diaphragm. Recovery occurs in reverse order.
• Onset & Duration: IV administration acts within 1 minute, peaks at 3 to 5 minutes, and lasts 25 to 40 minutes.
• Metabolism & Elimination: 60% to 80% protein-bound. Active 3-desacetyl metabolite has 50% to 70% potency of parent compound. Elimination half-life: 65 mins (infants), 41 mins (children), and 65 to 75 mins (adults).

3. Core Clinical Dosing

• Rapid-Sequence Intubation (RSI):
  • Adults: 0.1-0.2 mg/kg IV (onset 2-4 mins).
  • Pediatrics (7 weeks to 17 years): 0.15-0.2 mg/kg IV (onset 2.5-3 mins).
  • Neonates (<7 weeks): 0.1 mg/kg IV (onset 2.5-3 mins).
• Mechanical Ventilation & Surgery:
  • Adults: 0.08-0.1 mg/kg initial IV bolus, then 0.01-0.015 mg/kg every 12-15 mins as needed, or continuous infusion of 0.8-1.7 mcg/kg/min.
• Defasciculation: 0.01 mg/kg IV given 1-3 mins before succinylcholine in adults. Rare in pediatrics.

4. Reconstitution & Stability

• Reconstitution: Add 10 or 20 mL of Bacteriostatic Water to 10 or 20 mg vials (1 mg/mL). For neonates, use Sterile Water to avoid benzyl alcohol toxicity.
• Storage: Bacteriostatic water reconstitution lasts 5 days (room temp/refrigerated); Sterile Water is single-use and discarded within 24 hours. Do not mix with alkaline solutions.

5. Monitoring & Adverse Effects

• Monitoring: Use a peripheral nerve stimulator to monitor response (target: 1 to 2 twitches).
• Adverse Reactions: Major risks include bronchospasm, anaphylaxis, acute myopathy, prolonged paralysis, tachycardia, and hypotension. Minimal histamine release occurs.

📊 I can generate a quick reference dosing card or a cheat sheet comparing these pediatric vs. adult infusion rates for your clinical review.